Exhibitors at UBIFRANCE French Pavilion
Exhibitors at UBIFRANCE French Pavilion
Exhibitors at UBIFRANCE French Pavilion
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
TEXCELL<br />
Genavenir 5<br />
1 rue Pierre Fontaine<br />
91058 EVRY Cedex - FRANCE<br />
Phone: +33 1 60 91 33 10<br />
Fax: +33 1 64 93 33 24<br />
Email: ybarbier@texcell.fr<br />
Web site: www.texcell.fr<br />
Contact: Yves BARBIER<br />
Texcell is a world-renowned CSO company th<strong>at</strong> provides viral safety and immunology<br />
services in full compliance with GLP and GMP standards.<br />
Thanks to our in-depth experience of providing viral safety testing and virus valid<strong>at</strong>ion<br />
studies, we have provided support to a large number of products now licensed by<br />
the FDA, the EMEA and the MHW. Texcell is also your central lab for pre-clinical and<br />
clinical trials. We offer a dedic<strong>at</strong>ed technology pl<strong>at</strong>form in immunology. Based in<br />
France (Evry), we cre<strong>at</strong>ed in 2009 a subsidiary in USA (NY).<br />
TFCHEM<br />
Voie de l’Innov<strong>at</strong>ion - PharmaParc 2<br />
27100 VAL DE REUIL - FRANCE<br />
Phone: +33 2 32 09 01 16<br />
Fax: +33 2 32 25 07 64<br />
Email:<br />
geraldine.deliencourt@tfchemistry.com<br />
Web site: www.tfchemistry.com<br />
Contact: Géraldine<br />
DELIENCOURT-GODEFROY<br />
TFChem is a drug-discovery company, subsidiary of Sirona Biochem, which uses<br />
the fluorine <strong>at</strong>om properties to develop new glycomimetic compounds: GlycoMim ®<br />
technology.<br />
TFChem brings a unique solution to the drawbacks usually associ<strong>at</strong>ed with<br />
carbohydr<strong>at</strong>e-based drugs and unlocks the potential of sugar for the development<br />
of new, more potent and safer drugs. TFChem targets several major pharmaceutical<br />
domains but also cosmetics and biological ingredients for cells preserv<strong>at</strong>ion. TFChem<br />
is building partnerships and licensing activity with pharmaceutical and biotechnological<br />
companies.<br />
63